Search for: "Bausch & Lomb, Inc.,"
Results 1 - 20
of 108
Sort by Relevance
|
Sort by Date
24 Apr 2024, 8:24 am
Co. of America, 844 N.Y.S.2d 257, 46 A.D.3d 224 (1st Dep't 2007), 9 Bausch & Lomb Inc. v. [read post]
5 Jan 2023, 3:30 am
Bausch & Lomb, (2d. [read post]
24 Jun 2022, 9:08 pm
"To establish an occupational disease, the claimant must demonstrate a recognizable link between his or her condition and a distinctive feature of his or her employment[, and] the Board's decision as to whether to classify a certain medical condition as an occupational disease is a factual determination that will not be disturbed if supported by substantial evidence" (Matter of Urdiales v Durite Concepts Inc/Durite USA, 199 AD3d 1214, 1214 [2021] [internal quotation marks and… [read post]
24 Jun 2022, 9:08 pm
"To establish an occupational disease, the claimant must demonstrate a recognizable link between his or her condition and a distinctive feature of his or her employment[, and] the Board's decision as to whether to classify a certain medical condition as an occupational disease is a factual determination that will not be disturbed if supported by substantial evidence" (Matter of Urdiales v Durite Concepts Inc/Durite USA, 199 AD3d 1214, 1214 [2021] [internal quotation marks and… [read post]
6 Jun 2022, 9:17 am
Bausch & Lomb, Inc. [read post]
10 Dec 2020, 2:46 pm
Bausch & Lomb, Inc., 115 F.R.D. 308 (N.D. [read post]
10 Dec 2020, 2:46 pm
Bausch & Lomb, Inc., 115 F.R.D. 308 (N.D. [read post]
29 Oct 2019, 6:59 pm
Bausch & Lomb Inc., 909 F.2d1464, 1468 (Fed. [read post]
26 Sep 2019, 10:27 am
See, e.g., Sundance, 550 F.3d at 1361 n.2 & n.5 (allowing the defendant’s patent attorney-expert ‘testify as to patent office procedure generally’) (citing Bausch & Lomb, Inc. v. [read post]
21 Feb 2019, 12:11 pm
The story begins in 2001, when a lawyer at KM began to represent Bausch & Lomb (“Bausch”) in trademark matters. [read post]
21 Feb 2019, 8:45 am
Bausch & Lomb is also an indirect subsidiary ofValeant-CA and an affiliate of the above-listed entities.Valeant-CA contends that it has been a longstandingclient of Katten, both directly and through its subsidiaries.(...)Mukerjee and Soderstrom, then at Alston & Bird, represented Mylan throughout the district court litigation. [read post]
14 Sep 2018, 5:42 pm
Bausch & Lomb Inc., 909 F.2d 1464, 1468 (Fed. [read post]
20 Dec 2017, 9:10 am
Alcon Sheds Tears (and Certain Ad Claims) after Challenge by Bausch & Lomb After a challenge by rival contact lens solution manufacturer Bausch & Lomb, the NAD has recommended that Alcon Laboratories, Inc., discontinue claims about its Clear Care and Clear Care Plus contact lens solutions. [read post]
20 Dec 2017, 9:10 am
Alcon Sheds Tears (and Certain Ad Claims) after Challenge by Bausch & Lomb After a challenge by rival contact lens solution manufacturer Bausch & Lomb, the NAD has recommended that Alcon Laboratories, Inc., discontinue claims about its Clear Care and Clear Care Plus contact lens solutions. [read post]
13 Apr 2017, 11:54 am
Vitamin Health, Inc. v. [read post]
6 Dec 2016, 9:36 am
NAD Sees Clearly: Bausch & Lomb Must Discontinue Contact Lens Comfort Claims On December 2, 2016, the NAD recommended that Bausch & Lomb, Inc., discontinue claims that’s its PeroxiClear Contact Lens Peroxide Solution leave lenses feeling more comfortable than Alcon Laboratories, Inc. [read post]
16 Nov 2016, 8:56 am
Agency Enforcement FTC Requires Valeant to Divest Recently Acquired Paragon Valeant Pharmaceuticals International, Inc., parent company of Bausch+Lomb, has agreed to divest Paragon Holdings, which it acquired in May 2015, to settle charges that the acquisition violated the Clayton Act and the FTC Act. [read post]
9 Nov 2016, 6:35 am
Bausch & Lomb Canada Inc., provides a practical example of the potential pitfalls of fixed term contracts.Ms. [read post]
26 Apr 2016, 7:26 am
NAD Rules on Bausch & Lomb Ultra Contact Lens Claims The National Advertising Division (“NAD”) has recommended that Bausch & Lomb Inc. stop making certain representations about its line of Ultra contact lenses, but that other claims about certain chemical properties of Ultra lenses were supported by evidence. [read post]
13 Sep 2015, 9:21 pm
Watson Laboratories, Inc. et al. 1:15-cv-05591; filed July 16, 2015 in the District Court of New Jersey • Plaintiffs: Senju Pharmaceutical Co., Ltd.; Bausch & Lomb Inc.; Bausch & Lomb Pharma Holdings Corp. [read post]
